Merck KGaA

Merck KGaA is a German science and technology company headquartered in Darmstadt. Its shares trade on the Xetra platform in Frankfurt under the ticker MRK, and the company is included in the DAX 40 index. Its roots lie in a pharmacy founded in Darmstadt in the seventeenth century. The company is separate from Merck & Co. in the United States; in the United States and Canada it operates under the name EMD.

Merck KGaA works in three business areas. The healthcare arm develops medicines for multiple sclerosis, cancer, fertility treatment and cardiometabolic diseases. The life science arm offers laboratory products and materials used in biotechnology and drug manufacturing under the Millipore and Sigma-Aldrich brands. The electronics arm makes semiconductor materials, liquid crystals used in displays, and surface solutions. The company has a partnership limited by shares structure, in which the Merck family plays a significant role.

Those following Merck KGaA stock typically watch developments in the drug research pipeline, demand for bioprocess and laboratory products, semiconductor materials orders, and acquisition activity. On the MRK.DE page at Lzzo.com, the price is shown in euros, the currency it trades in, and the page includes a historical price chart, technical indicators and the data source.